Literature DB >> 12165444

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: alveolar soft part sarcoma.

Avery Sandberg1, Julia Bridge.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12165444     DOI： 10.1016/s0165-4608(02)00592-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  6 in total

1.  Alveolar soft part sarcoma of the larynx.

Authors:  Tahir Altuğ; Ender Inci; Melih Güven Güvenç; Deniz Tuna Edizer; Sergülen Dervişoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-25       Impact factor: 2.503

2.  Integrative metabolome and transcriptome profiling reveals discordant glycolysis process between osteosarcoma and normal osteoblastic cells.

Authors:  Kai Chen; Chunyan Zhu; Ming Cai; Dong Fu; Biao Cheng; Zhengdong Cai; Guodong Li; Jilong Liu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-12       Impact factor: 4.553

Review 3.  Surgical management and outcome of spinal alveolar soft part sarcoma (ASPA): a case series of five patients and literature review.

Authors:  Chenglong Zhao; Xin Gao; Jian Yang; Zhenxi Li; Xiaopan Cai; Tao Tan; Tianhui Hou; Wangjun Yan; Xinghai Yang; Cheng Yang; Tielong Liu; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2017-02-06       Impact factor: 2.754

4.  Alveolar soft part sarcoma of flexure tendon.

Authors:  Chatchai Pruksapong; Kantang Satayasoontorn
Journal:  J Surg Case Rep       Date:  2017-12-21

5.  Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.

Authors:  Tomoyasu Yoshihiro; Kenji Tsuchihashi; Kenta Nio; Shuji Arita; Takafumi Nakano; Ryuji Yasumatsu; Rina Jiroumaru; Hiroshi Ariyama; Hitoshi Kusaba; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

6.  Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets.

Authors:  David G Covell; Anders Wallqvist; Susan Kenney; David T Vistica
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.